Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024Business Wire • 04/18/24
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse PopulationsBusiness Wire • 03/28/24
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome SequencingBusiness Wire • 03/05/24
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Business Wire • 02/07/24
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI SystemBusiness Wire • 02/06/24
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy ApplicationsBusiness Wire • 02/06/24
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBTBusiness Wire • 02/05/24
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024Business Wire • 01/16/24
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)Business Wire • 01/08/24
Twist Bioscience (TWST) Soars 12.5%: Is Further Upside Left in the Stock?Zacks Investment Research • 12/15/23
DNA-Maker Twist Bioscience Catapults 21% As 'Solid' Outlook That Tops Its PeersInvestors Business Daily • 11/17/23
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial ResultsBusiness Wire • 11/17/23